MedPath

Health Institutes of Turkey

Ownership
Private
Employees
-
Market Cap
-
Website

Observational National Vaccine Study

Completed
Conditions
COVID-19 Infection
Interventions
Biological: Taking biological samples (blood) and keeping records with phone calls
First Posted Date
2023-05-18
Last Posted Date
2024-05-24
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
200
Registration Number
NCT05863429
Locations
🇹🇷

T.R. Ministry of Health Kartal Dr. Lütfi Kirdar City Hospital Infectious Diseases, Istanbul, Turkey

🇹🇷

Kayseri City Training and Research Hospital, Department of Infectious Diseases and Clinical Microbiology, Kayseri, Turkey

🇹🇷

EskiÅŸehir City Hospital Internal Medicine, EskiÅŸehir, Turkey

and more 5 locations

Efficacy, Immunogenicity, and Safety of TURKOVAC Vaccine Versus the CoronaVac Vaccine Against COVID-19 in Healthy Adolescent

Phase 2
Completed
Conditions
COVID-19
Sars-CoV-2 Infection
Interventions
Biological: TURKOVAC
Biological: CoronaVac
First Posted Date
2022-02-09
Last Posted Date
2024-05-28
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
1
Registration Number
NCT05230940
Locations
🇹🇷

T.R. Ministry of Health Istanbul Provincial Health Directorate Prof. Dr. Cemil Taşçıoğlu City Hospital, Pediatric Infectious Diseases Clinic, Istanbul, Turkey

🇹🇷

Health Sciences University Adana City Training and Research Hospital, Pediatric Health and Diseases, Adana, Turkey

🇹🇷

Çukurova University Faculty of Medicine Department of Pediatric Infectious Diseases, Adana, Turkey

and more 11 locations

Phase 2b Booster Vaccination (TURKOVAC) Against COVID-19

Phase 2
Completed
Conditions
COVID-19
Sars-CoV-2 Infection
Interventions
Biological: TURKOVAC-Dollvet
Biological: TURKOVAC-Koçak
First Posted Date
2022-01-27
Last Posted Date
2023-11-29
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
65
Registration Number
NCT05210179
Locations
🇹🇷

T.R. Ministry of Health Kayseri City Training and Research Hospital, Infectious Diseases and Clinical Microbiology Department, Kayseri, Turkey

🇹🇷

T.R. Ministry of Health Ankara City Hospital, Infectious Diseases and Clinical Microbiology Clinic, Ankara, Turkey

🇹🇷

Ä°stanbul University CerrahpaÅŸa, CerrahpaÅŸa Faculty of Medicine, Department of Internal Medicine - Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

and more 6 locations

Phase 3 Booster Vaccination Against COVID-19

Phase 3
Completed
Conditions
Sars-CoV-2 Infection
COVID-19
Interventions
Biological: CoronaVac
Biological: Turkovac
First Posted Date
2021-10-14
Last Posted Date
2024-02-29
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
4340
Registration Number
NCT05077176
Locations
🇹🇷

T.R. Ministry of Health Antalya Training And Research Hospital, Antalya, Turkey

🇹🇷

T.R. Ministry of Health Abant Izzet Baysal University Training and Research Hospital, Bolu, Turkey

🇹🇷

CerrahpaÅŸa Faculty of Medicine, Department of Internal Medicine - Department of Infectious Diseases and Clinical Microbiology, Istanbul, Turkey

and more 38 locations

Evaluation of the Efficacy, Safety and Immunogenicity of Inactivated COVID 19 Vaccine(TURKOVAC) in Healthy Population of 18 and 64 Years of Age (Both Inclusive):a Randomized, Double-blind, Phase IIb Clinical Trial

Phase 2
Conditions
Covid19
Interventions
Biological: Triple dose vaccination by inactivated Covid19 vaccine
First Posted Date
2021-09-05
Last Posted Date
2021-09-05
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
200
Registration Number
NCT05035238
Locations
🇹🇷

Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), Kayseri, Turkey

Clinical Trial For Early SARS-CoV-2 (COVID-19) Treatment

Phase 3
Completed
Conditions
Covid19
Interventions
First Posted Date
2021-07-29
Last Posted Date
2021-07-29
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
1120
Registration Number
NCT04981379
Locations
🇹🇷

Ankara City Hospital, Ankara, Turkey

🇹🇷

Istanbul University Istanbul Medicine Faculty, Istanbul, Turkey

🇹🇷

Sancaktepe Åžehit Prof. Dr. Ä°lhan Varank Training and Research Hospital, Istanbul, Turkey

and more 3 locations

Booster Vaccination Against COVID-19

Phase 2
Completed
Conditions
Sars-CoV-2 Infection
COVID-19
Interventions
Biological: Turkovac
Biological: CoronaVac
First Posted Date
2021-07-28
Last Posted Date
2023-11-29
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
222
Registration Number
NCT04979949
Locations
🇹🇷

Ankara City Hospital Internal Medicine Clinic, Ankara, Turkey

🇹🇷

T.R. Ministry of Health Kartal Dr. Lütfi Kirdar City Hospital Infectious Diseases, Istanbul, Turkey

🇹🇷

Sancaktepe Martyr Professor Dr. Ä°lhan Varank Training and Research Hospital Infectious Diseases and Clinical Microbiology Clinic, Istanbul, Turkey

and more 1 locations

Efficacy, Immunogenicity, and Safety of the Inactivated COVID-19 Vaccine (TURKOVAC) Versus the CoronaVac Vaccine

Phase 3
Completed
Conditions
Covid19
Interventions
Biological: CoronaVac
Biological: TURCOVAC
First Posted Date
2021-06-28
Last Posted Date
2024-02-29
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
1290
Registration Number
NCT04942405
Locations
🇹🇷

Gazi University Faculty of Medicine, Department of Infectious Diseases, Ankara, Turkey

🇹🇷

T.R. Ministry of Health Ankara Keçiören Sanatorium Ataturk Chest Diseases and Thoracic Surgery Training and Research Hospital, Ankara, Turkey

🇹🇷

T.R. Ministry of Health Ankara City Hospital, Infectious Diseases and Clinical Microbiology Clinic, Ankara, Turkey Region, Turkey

and more 26 locations

Efficacy, Immunogenicity and Safety of Inactivated ERUCOV-VAC Compared With Placebo in COVID-19

Phase 2
Completed
Conditions
COVID-19
Interventions
Other: Placebo
Biological: ERUCOV-VAC 6 µg/0.5 ml Vaccine
Biological: ERUCOV-VAC 3 µg/0.5 ml Vaccine
First Posted Date
2021-04-01
Last Posted Date
2023-08-03
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
250
Registration Number
NCT04824391
Locations
🇹🇷

Erciyes University, Kayseri, Turkey

Safety and Immunogenicity of Two Different Strengths of the Inactivated COVID-19 Vaccine ERUCOV-VAC

Phase 1
Completed
Conditions
COVID-19 Vaccine
Interventions
Biological: ERUCOV-VAC
Other: Placebo Vaccine
First Posted Date
2020-12-31
Last Posted Date
2023-02-14
Lead Sponsor
Health Institutes of Turkey
Target Recruit Count
44
Registration Number
NCT04691947
Locations
🇹🇷

Erciyes University Hakan Çetinsaya Iyi Klinik Uygulama ve Arastirma Merkezi, IKUM (Center for GCP), Kayseri, Turkey

© Copyright 2025. All Rights Reserved by MedPath